Market Overview
Overview
- The global clinical grade wearables market was estimated at USD 137.7 billion in 2025.
- The market is expected to grow from USD 158.2 billion in 2026 to USD 617.9 billion in 2035, at a CAGR of 16.3% during the forecast period, according to Brevintel analysis The market is driven by numerous factors, such as increasing awareness about physical fitness, wearable devices among the population in developing countries, and growing prevalence of chronic diseases globally.
- The clinical grade wearables market comprises medical grade, sensor enabled wearable devices designed to continuously or periodically monitor physiological parameters for clinical diagnosis, disease management, treatment monitoring, and remote patient care.
- These devices are clinically validated and comply with regulatory standards to ensure high accuracy, safety, and reliability.
- They enable real time health data collection, facilitate informed clinical decision making, support remote patient monitoring, and improve patient outcomes by enhancing disease detection, treatment adherence, and personalised healthcare delivery.
- The clinical grade wearables market is witnessing increasing competitive activity driven by continuous innovation and expanding product portfolios. iRhythm Technologies, Boston Scientific, BioIntelliSense, Withings, and Omron Healthcare are among the leading players operating in the market.
- These companies primarily focus on product innovation, research and development, regulatory compliance, strategic collaborations, and geographic expansion to maintain their competitive advantage.
- The market has increased from USD 93.8 billion in 2022 and reached USD 120.1 billion in 2024, with a historic growth rate of 13.2%.
- The growing prevalence of chronic diseases is a key factor driving the growth of the clinical grade wearables market, as it is increasing the demand for continuous health monitoring and remote patient management solutions.
- Chronic conditions such as diabetes, cardiovascular diseases, hypertension, and respiratory disorders require regular monitoring to enable timely clinical intervention and improve overall disease management.
- According to the International Diabetes Federation, the global number of adults living with diabetes is projected to increase from 589 million in 2024 to approximately 853 million by 2050, representing an increase of nearly 46%.
- Similarly, the World Health Organization estimates that approximately 1.28 billion adults aged 30–79 years worldwide are living with hypertension, with a significant proportion remaining undiagnosed or inadequately controlled.
Segmentation Analysis
Segment Overview
- Based on devices, the clinical grade wearables market is segmented into activity/fitness monitors, diabetes devices, cardiac monitors, neurological monitors, respiratory monitors, body & temperature monitors, in-ear devices and other devices.
- The activity/fitness monitors segment accounted for a dominant market share of 25% in 2025.
Application Outlook
- Based on application, the clinical grade wearables market is segmented into cardiac health, obesity control, diabetes care, fitness monitoring, sleep tracking, and other applications.
- The fitness monitoring segment represented the dominating application category in the market, accounting for 23% market share in 2025.
End Use Outlook
- Based on end use, the global clinical-grade wearables market is segmented into hospitals, home care settings, and other end users.
- The home care setting segment represented the dominating end use category in the clinical grade wearables market, accounting for 60.2% market share in 2025.
- The North America market accounted for the leading regional share of 40.4% in 2025 and is anticipated to demonstrate significant growth over the forecast period.
- Europe market accounted for USD 30.1 billion in 2025 and is anticipated to show lucrative growth over the forecast period.
- The Asia Pacific region is projected to show a lucrative growth of about 17% during the forecast period.
Competitive Landscape
Overview
- A few of the prominent players operating in the clinical grade wearables industry include:
- Koninklijke Philips N.V. is a prominent participant in the clinical-grade wearables market, leveraging its expertise in connected care, remote patient monitoring, and digital health technologies to support clinical decision-making and patient management.
- Masimo is a well-established player in the clinical-grade wearables market, driven by its innovative biosensor technologies and noninvasive monitoring solutions that enable continuous tracking of vital health parameters across care settings